Cargando…
Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
Mallon discusses a new study that describes associations between apoC-III polymorphisms and triglyceride concentrations in a large population of HIV-infected patients from a variety of ethnic backgrounds.
Autor principal: | Mallon, Patrick W. G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351918/ https://www.ncbi.nlm.nih.gov/pubmed/16420104 http://dx.doi.org/10.1371/journal.pmed.0030085 |
Ejemplares similares
-
Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020) -
Unlocking the potential of ancient fish DNA in the genomic era
por: Oosting, Tom, et al.
Publicado: (2019) -
AI for social good: unlocking the opportunity for positive impact
por: Tomašev, Nenad, et al.
Publicado: (2020) -
Chemical biology: a toolbox to unlock neurochemical epigenetics?
por: Özcelik, Dennis
Publicado: (2020) -
Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
por: Perumal Kannabiran, Bhavani, et al.
Publicado: (2017)